Wird geladen...

Recombinant immunotoxins and other therapies for relapsed/refractory hairy cell leukemia

Standard treatment for hairy cell leukemia (HCL) is markedly effective, but the constant decrease in disease-free survival, together with the presence of minimal residual disease (MRD), suggests that few if any are cured. HCL cells in MRD are always strongly CD20+ and CD22+, and also CD25 + unless t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Leuk Lymphoma
Hauptverfasser: KREITMAN, ROBERT J., ARONS, EVGENY, STETLER-STEVENSON, MARYALICE, FITZGERALD, DAVID J. P., WILSON, WYNDHAM H., PASTAN, IRA
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7435070/
https://ncbi.nlm.nih.gov/pubmed/21599609
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.565843
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!